Elsevier

Atherosclerosis

Volume 181, Issue 1, July 2005, Pages 149-158
Atherosclerosis

Clinical Research
Antioxidant effect of virgin olive oil in patients with stable coronary heart disease: a randomized, crossover, controlled, clinical trial

https://doi.org/10.1016/j.atherosclerosis.2004.12.036Get rights and content

Abstract

The Mediterranean diet, in which olive oil is the main source of fat, has been associated with a reduced incidence of coronary heart disease (CHD) and low blood pressure levels. Virgin olive oil (VOO), besides containing monounsaturated fat, is rich in phenolic compounds (PC) with antioxidant properties. The aim of this study was to examine the antioxidant and anti-hypertensive effect of two similar olive oils, but with differences in their PC (refined: 14.7 mg/kg versus virgin: 161.0 mg/kg), in 40 males with stable CHD. The study was a placebo controlled, crossover, randomized trial. A raw daily dose of 50 mL of VOO and refined olive oil (ROO) were sequentially administered over two periods of 3 weeks, preceded by 2-week washout periods in which ROO was used. Lower plasma oxidized LDL (p < 0.001) and lipid peroxide levels (p = 0.003), together with higher activities of glutathione peroxidase (p = 0.033), were observed after VOO intervention. Systolic blood pressure decreased after intake of VOO (p = 0.001) in hypertensive patients. No changes were observed in diastolic blood pressure, glucose, lipids, and antibodies against oxidized LDL. Consumption of VOO, rich in PC, could provide beneficial effects in CHD patients as an additional and complementary intervention to the pharmacological treatment.

Introduction

The Mediterranean diet, in which olive oil is the main source of fat, is associated with a decrease in overall and cardiovascular mortality [1]. Diets rich in monounsaturated fatty acids (MUFA) are used to manage cardiovascular disease risk, provided that they do not exceed the saturated fatty acid (SFA) recommendation and compromise weight control [2]. On the other hand, olive oil-rich diets have shown to reduce low-density lipoprotein (LDL) oxidation [3].

Oxidation of LDL is a hallmark for atherosclerosis and coronary heart disease (CHD) development [4]. One of the earliest steps in the generation of oxidized LDL (oxLDL) is the lipid peroxidation of polyunsaturated fatty acids (PUFA). Tissue membranes that are rich in PUFA are more susceptible to oxidation by free radicals than membranes rich in MUFA [5]. However, lipid peroxidation, and its chain reaction in LDL, can be interrupted if LDL lipids are protected from free radicals by antioxidants.

Olive oil is rich in MUFA and antioxidant compounds. The concentration of antioxidants in olive oils is influenced by the olive oil extraction procedures. Virgin olive oil (VOO), obtained exclusively by physical procedures, is much more than a MUFA fat because it contains relatively high amounts of antioxidants, mainly phenolic compounds (PC). However, PC are lost when the olive oil is refined. The main PC in olive oil are oleuropein and ligstroside aglycones which by hydrolysis both give hydroxytyrosol (OHT) and tyrosol (T) [6]. Both free forms of T, OHT and their secoroid and conjugated forms, represent around 80% of the PC present in a virgin olive oil [7]. Olive oil PC have been shown to protect LDL from lipid peroxidation in in vitro experiments [8]. Animal studies suggest a protective effect of olive oil phenolics on LDL oxidation [9]. However, the information from randomized, crossover, controlled intervention trials in humans, which provides first level of scientific evidence, on the in vivo effects of olive oil rich in PC is scarce and controversial [10], [11], [12], [13].

Compared with a saturated fat diet, the Mediterranean diet has been found to be associated with lower levels of blood pressure [14]. In the few studies concerning the relationship between olive oil consumption and blood pressure levels, olive oil consumption was effective in lowering blood pressure in hypertensive patients [15], [16]. Hypertension is related to endothelial dysfunction which contributes to make the atherosclerotic plaque more unstable, thus increasing the risk of secondary events in CHD patients [17]. On the other hand, a relationship exists between oxidative stress and LDL oxidation with endothelial dysfunction [18].

Thus, the first aim of the present study was to evaluate the effect of both VOO and refined virgin olive oil (ROO) with differences in their PC concentration, on oxidative stress in stable CHD patients. The second aim was to compare the effects of olive oil on blood pressure in hypertensive and stable CHD patients. A randomized, crossover, placebo controlled trial study was designed.

Section snippets

Olive oil characteristics

The olive oils selected, ROO and VOO, came from the same cultivar and harvest and were prepared for the present clinical trial. Fatty acid composition, α-tocopherol, and β-carotene content were similar in the two olive oils. MUFA percentage was 74 and 77%; SFA percentage was 16 and 15%; and PUFA percentage was 11 and 9%, in ROO and VOO, respectively. The olive oil dose (50 mL) per day administered to the patients contained 0 and 0.15 mg of β-carotene; 5.99 and 8.73 mg of α-tocopherol; and 0.62 and

Baseline characteristics

Table 2 shows the basal characteristics of the participants at the beginning of the study. No significant differences in age, body mass index, physical activity, blood pressure, glycaemia values, blood lipid profile, and biomarkers of oxidative/antioxidative status were observed between the two groups of olive oil administration order at the beginning of the study. The incidence of diabetes, AMI, number of coronary vessels affected, medical treatment, and smoking habits were similar in the two

Discussion

In the present study, we compared the effects of two similar olive oils, but with differences in their phenolic content, on oxidative/antioxidative biomarkers and blood pressure levels in stable CHD patients. The design of the present study allowed an independent assessment of the effects of the minor components from olive oil ingestion. From our results, consumption of VOO, rich in PC, decreased oxidative stress and increased the antioxidant endogenous defence more than refined olive oil with

Summary

Consumption of VOO during 3 weeks led to a decrease of in vivo oxLDL and lipid peroxide plasma levels, together with an increase in GSH-Px activity, higher than those observed after refined olive oil consumption. Furthermore, a decrease in the SBP was observed after VOO intervention in hypertensive stable CHD patients, especially those who were SBP  140 mmHg at the beginning of the study. From our knowledge, the present study is the first report on the possible protective effect of olive oil rich

Acknowledgments

Supported by grants: FEDER 2FD097-0297-CO2-01 and by Federació de Cooperatives Agràries de Catalunya.

References (41)

  • S.A. Wiseman et al.

    Dietary non-tocopherol antioxidants present in extra virgin olive oil increase the resistance of low density lipoproteins to oxidation in rabbits

    Atherosclerosis

    (1996)
  • T. Weinbrenner et al.

    High oxidative stress in patients with stable coronary heart disease

    Atherosclerosis

    (2003)
  • E.I. Waddington et al.

    Fatty acid oxidation products in human atherosclerotic plaque: an analysis of clinical and histopathological correlates

    Atherosclerosis

    (2003)
  • F. Visioli et al.

    Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents

    Atherosclerosis

    (1995)
  • C.M. Aguilera et al.

    Virgin olive and fish oils enhance the hepatic antioxidant defence system in atherosclerotic rabbits

    Clin Nutr

    (2003)
  • R. Masella et al.

    Extra virgin olive oil biophenols inhibit cell-mediated oxidation of LDL by increasing the mRNA transcription of glutathione-related enzymes

    J Nutr

    (2004)
  • A. Trichopoulou et al.

    Adherence to a Mediterranean diet and survival in a Greek population

    N Engl J Med

    (2003)
  • P.M. Kris-Etherton

    Monounsaturated fatty acids and risk of cardiovascular disease

    Circulation

    (1999)
  • S. Parthasarathy et al.

    Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis

    Proc Natl Acad Sci USA

    (1990)
  • P.D. Reaven et al.

    Effects of linoleate-enriched and oleate-enriched diets in combination with alpha-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans

    Arterioscler Thromb

    (1994)
  • Cited by (0)

    1

    SOLOS (Spanish Olive Oil Study) Study Investigators: Alcántara M, Covas MI, Fitó M, Marrugat J, Schröder H, Weinbrenner T, Alcántara M, Muñoz D (Unitat de Lipids i Epidemiologia Cardiovascular, Institut Muncipal d’Investigació Mèdica), de la Torre R, Farré M, Menoyo E, Miró-Casas E, Pujadas-Bastardes M, Closas N (Unitat de Farmacologia, Institut Muncipal d’Investigació Mèdica), and de la Torre-Boronat C, Gimeno E, Lamuela R and López MC (Departament de Bromatologia i Nutricio, Facultat de Farmacia, Universitat de Barcelona).

    View full text